Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-asparaginase encapsulated in erythrocytes

EU orphan designation number: EU/3/06/409   
Active ingredient: L-asparaginase encapsulated in erythrocytes
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: ERYtech Pharma S.A.
60 avenue Rockefeller, Bātiment Adenine, F-69008 Lyon, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/10/2006 Centralised Orphan - Designation EMEA/OD/033/06 (2006)5241 of 27/10/2006